Genentech: latest news - GoINPHARMA
Sunday, 24 March 2019 - 18:34

Genentech

New spate of job cuts: Amgen and Genentech announce 330 layoffs

Amgen is starting a large restructuring plan, especially affecting its Californian headquarters in Thousand Oaks, currently employing approximately 5,000 people. The plan will result in an immediate cut of approximately 200 R&D jobs. Amgen announced a reorganization concerning 500 Thousand…

Nimbus signs cooperation agreement with Celgene

US-based Nimbus Therapeutics (Cambridge MA-US) has signed a new, strategic cooperation agreement with a drug-making multinational. This time the new partner is Celgene and the alliance covers two programs in pre-clinical stage, focused on a Tyk2 inhibitor and STING non-nucleotide…

FDA, priority review for Genentech/Roche’s emicizumab in haemophilia A

Genentech, a member of the Roche Group, announced that FDA accepted a sBLA (Biologics License Application) and granted Priority Review for emicizumab as a prophylaxis treatment for adults, adolescents and children with hemophilia A with factor VIII inhibitors. As part…